US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

UpStream Bio Inc.

6.61

-0.3600-5.16%

Volume:538.55K

Turnover:3.59M

Market Cap:362.04M

PE:-2.30

High:7.11

Open:7.00

Low:6.46

Close:6.97

52wk High:33.68

52wk Low:5.85

Shares:54.77M

Float Shares:46.68M

Volume Ratio:0.92

T/O Rate:1.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8758

EPS(LYR):-2.6636

ROE:-46.05%

ROA:-30.28%

PB:1.34

PE(LYR):-2.48

Loading ...

Overview Company News Filings

LifeSci Capital Sticks to Its Buy Rating for Upstream Bio, Inc. (UPB)

Upstream Bio Price Target Raised to $9.00/Share from $8.00 by JP Morgan

J.P. Morgan Keeps Their Hold Rating on Upstream Bio, Inc. (UPB)

Analysts Offer Insights on NA Companies: Upstream Bio, Inc. (UPB) and Circle Internet Group, Inc. Class A (CRCL)

Matt Phipps Initiates Buy on Upstream Bio, Citing Favorable FDA Progress and Best-in-Class Potential for Verekitug

Upstream Bio price target lowered to $25 from $43 at Truist

Upstream Bio Q2 EPS $(0.73) Beats $(0.76) Estimate, Sales $773.000K Beat $430.714K Estimate

Benzinga Earnings

Gain Therapeutics Q2 Net Loss Per Share Narrows as R&D Expenses Fall

Upstream Bio Posts Corporate Presentation Highlighting Verekitug Phase 3 Plans in Severe Asthma, CRSwNP

Upstream Bio Q2 Net Loss Narrows Slightly on Lower R&D Costs

Upstream Bio Inc Q2 Collaboration Revenue USD 773 Thousand

THOMSON REUTERS

Press Release: Onity Group Announces Second Quarter 2026 Results

Upstream Bio Inc Expected to Post a Loss of 76 Cents a Share - Earnings Preview

Arbor Realty Trust Reports Second Quarter 2026 Results and Declares Dividend of $0.17 per Share

Top Executive Makes Strategic Move With Upstream Bio Stock

Upstream Bio presents new responder analyses from VIBRANT trial of verekitug

Upstream Bio says Phase 2 VIBRANT trial shows verekitug improves nasal polyp score in about 80% of CRSwNP patients

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in Crswnp in Significant Majority of Participants Treated With Verekitug in the Phase 2 Vibrant Trial at Eaaci 2026

THOMSON REUTERS

Upstream Bio Inc : JP Morgan Cuts to Neutral From Overweight; Cuts Target Price to $8 From $35

THOMSON REUTERS

Upstream Bio Shareholders Elect Directors, Ratify 2026 Auditor

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/UPB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"UPB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UPB\",,,,,undefined,":{"symbol":"UPB","market":"US","secType":"STK","nameCN":"UpStream Bio Inc.","latestPrice":6.61,"timestamp":1787601600000,"preClose":6.97,"halted":0,"volume":538545,"delay":0,"changeRate":-0.05164992826398844,"floatShares":46680775,"shares":54771041,"eps":-2.875781,"marketStatus":"Pre-Mkt","change":-0.36,"latestTime":"08-25 08:02:19 EDT","open":7,"high":7.11,"low":6.46,"amount":3587296.929468,"amplitude":0.093257,"askPrice":14.22,"askSize":35,"bidPrice":6.11,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.875781,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":6.61,"postHourTrading":{"tag":"盘后","latestPrice":6.61,"preClose":6.61,"latestTime":"19:30 EDT","volume":6066,"amount":40097.63,"timestamp":1787614207078,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9235650440904627,"impliedVol":3.5035,"impliedVolPercentile":0.948},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UPB\",,,,,undefined,":{"symbol":"UPB","floatShares":46680775,"roa":"-30.28%","roe":"-46.05%","lyrEps":-2.663615,"volumeRatio":0.9235650440904627,"shares":54771041,"dividePrice":0,"high":7.11,"amplitude":0.093257,"preClose":6.97,"low":6.46,"week52Low":5.85,"pbRate":"1.34","psRate":"114.64","week52High":33.68,"institutionHeld":0,"latestPrice":6.61,"committee":0.702128,"eps":-2.875781,"divideRate":0,"volume":538545,"delay":0,"ttmEps":-2.875781,"open":7,"prevYearClose":27.15,"prevWeekClose":6.97,"prevMonthClose":6.31,"prevQuarterClose":6.92,"fiveDayClose":7.14,"twentyDayClose":6.4,"sixtyDayClose":8.32},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/UPB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"UPB","fiscalQuarterEnding":"2026/06","expectedEps":-0.78,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-0.73},{"market":"US","date":"2026-05-13","symbol":"UPB","fiscalQuarterEnding":"2026/03","expectedEps":-0.8,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2026-03-26","symbol":"UPB","fiscalQuarterEnding":"2025/12","expectedEps":-0.73,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"pre","actualEps":-0.79},{"market":"US","date":"2025-05-06","symbol":"UPB","fiscalQuarterEnding":"2025/03","expectedEps":-0.49,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"pre","actualEps":-0.51},{"market":"US","date":"2025-03-12","symbol":"UPB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"UPB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"UPB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.6667,"hold":0.2222,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1781496000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/UPB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"UPB","date":"2026-08-24","current":-2.298506,"percent":0.926882,"low":-36.237602,"twenty":-12.812645,"median":-8.026772,"eighty":-3.532065,"high":-2.055104,"avg":-9.578238,"sd":7.003475,"marketCap":381754155},"quantilePoints":[{"date":"2024-10-11","current":-21.547111,"twenty":-21.096119,"median":-20.419631,"eighty":-19.743142,"marketCap":872808815},{"date":"2024-10-18","current":-29.91246,"twenty":-29.856691,"median":-29.151973,"eighty":-22.814588,"marketCap":1211664002},{"date":"2024-10-25","current":-33.154958,"twenty":-33.128498,"median":-29.931472,"eighty":-28.137991,"marketCap":1343007876},{"date":"2024-10-31","current":-32.943274,"twenty":-33.154958,"median":-32.429578,"eighty":-29.151973,"marketCap":1334433205},{"date":"2024-11-08","current":-35.748083,"twenty":-33.28726,"median":-32.943274,"eighty":-29.633615,"marketCap":1448047598},{"date":"2024-11-15","current":-26.036965,"twenty":-33.27403,"median":-32.40745,"eighty":-26.47861,"marketCap":1390295829},{"date":"2024-11-22","current":-17.866537,"twenty":-33.154958,"median":-29.91246,"eighty":-25.555171,"marketCap":954019497},{"date":"2024-11-29","current":-21.951751,"twenty":-33.154958,"median":-29.151973,"eighty":-21.870823,"marketCap":1172157663},{"date":"2024-12-06","current":-22.082237,"twenty":-33.144374,"median":-26.689395,"eighty":-21.903572,"marketCap":1179125222},{"date":"2024-12-13","current":-20.486294,"twenty":-33.088806,"median":-26.036965,"eighty":-21.589777,"marketCap":1093906626},{"date":"2024-12-20","current":-16.672089,"twenty":-32.969734,"median":-24.742143,"eighty":-20.201232,"marketCap":890239542},{"date":"2024-12-27","current":-19.517686,"twenty":-32.858694,"median":-23.382078,"eighty":-19.472518,"marketCap":1042185906},{"date":"2025-01-03","current":-16.36093,"twenty":-32.784605,"median":-22.553994,"eighty":-19.153329,"marketCap":873624596},{"date":"2025-01-10","current":-16.250519,"twenty":-32.617811,"median":-22.077219,"eighty":-18.486847,"marketCap":867728970},{"date":"2025-01-17","current":-10.92067,"twenty":-31.635576,"median":-21.951751,"eighty":-17.320504,"marketCap":583131018},{"date":"2025-01-24","current":-10.810259,"twenty":-29.950484,"median":-21.600443,"eighty":-16.501454,"marketCap":577235392},{"date":"2025-01-31","current":-11.041119,"twenty":-29.91246,"median":-20.852659,"eighty":-16.230444,"marketCap":589562611},{"date":"2025-02-07","current":-8.561886,"twenty":-29.633615,"median":-19.703378,"eighty":-11.472726,"marketCap":457179006},{"date":"2025-02-14","current":-7.3574,"twenty":-29.151973,"median":-19.472518,"eighty":-10.92067,"marketCap":392863085},{"date":"2025-02-21","current":-8.260764,"twenty":-28.137991,"median":-19.276941,"eighty":-10.810259,"marketCap":441100026},{"date":"2025-02-28","current":-7.839194,"twenty":-27.097043,"median":-19.030874,"eighty":-9.965112,"marketCap":418589453},{"date":"2025-03-07","current":-8.451474,"twenty":-26.562924,"median":-18.338294,"eighty":-8.834903,"marketCap":451283380},{"date":"2025-03-14","current":-7.737899,"twenty":-26.318012,"median":-17.866537,"eighty":-8.491624,"marketCap":485986508},{"date":"2025-03-21","current":-6.875286,"twenty":-26.085144,"median":-16.857781,"eighty":-8.411325,"marketCap":431809204},{"date":"2025-03-28","current":-5.816236,"twenty":-26.012875,"median":-16.36093,"eighty":-8.168077,"marketCap":365294494},{"date":"2025-04-04","current":-5.380659,"twenty":-25.645507,"median":-16.240482,"eighty":-7.936302,"marketCap":337937638},{"date":"2025-04-11","current":-5.466066,"twenty":-24.254326,"median":-13.751211,"eighty":-7.734483,"marketCap":343301728},{"date":"2025-04-17","current":-7.191293,"twenty":-23.886958,"median":-11.472726,"eighty":-7.5722,"marketCap":451656335},{"date":"2025-04-25","current":-7.652492,"twenty":-23.286723,"median":-11.041119,"eighty":-7.514132,"marketCap":480622419},{"date":"2025-05-02","current":-7.693506,"twenty":-22.857123,"median":-10.850408,"eighty":-7.502769,"marketCap":483198327},{"date":"2025-05-09","current":-6.005612,"twenty":-22.499792,"median":-10.810259,"eighty":-7.378434,"marketCap":475536334},{"date":"2025-05-16","current":-5.964849,"twenty":-22.162536,"median":-10.288315,"eighty":-7.189481,"marketCap":472308712},{"date":"2025-05-23","current":-6.324914,"twenty":-22.076215,"median":-9.921951,"eighty":-6.77963,"marketCap":500819374},{"date":"2025-05-30","current":-6.352089,"twenty":-22.02402,"median":-9.013568,"eighty":-6.524152,"marketCap":502971123},{"date":"2025-06-06","current":-7.357554,"twenty":-21.951751,"median":-8.668839,"eighty":-6.524152,"marketCap":582585803},{"date":"2025-06-13","current":-7.853492,"twenty":-21.855392,"median":-8.531773,"eighty":-6.551855,"marketCap":621855206},{"date":"2025-06-20","current":-7.228474,"twenty":-21.688772,"median":-8.441437,"eighty":-6.588317,"marketCap":572364999},{"date":"2025-06-27","current":-7.432284,"twenty":-21.589777,"median":-8.421362,"eighty":-6.683973,"marketCap":588503110},{"date":"2025-07-03","current":-7.60892,"twenty":-21.547111,"median":-8.293047,"eighty":-6.875286,"marketCap":602489473},{"date":"2025-07-11","current":-8.043715,"twenty":-21.219023,"median":-8.229183,"eighty":-7.004282,"marketCap":636917443},{"date":"2025-07-18","current":-7.500221,"twenty":-20.486294,"median":-8.00983,"eighty":-7.116503,"marketCap":593882481},{"date":"2025-07-25","current":-9.06956,"twenty":-20.325696,"median":-7.964314,"eighty":-7.165671,"marketCap":718145935},{"date":"2025-08-01","current":-10.401121,"twenty":-19.703378,"median":-8.043715,"eighty":-7.186764,"marketCap":823581592},{"date":"2025-08-08","current":-8.173881,"twenty":-19.517686,"median":-8.19076,"eighty":-7.191293,"marketCap":853925323},{"date":"2025-08-15","current":-9.608438,"twenty":-19.472518,"median":-8.256445,"eighty":-7.228474,"marketCap":1003793530},{"date":"2025-08-22","current":-9.154334,"twenty":-19.472518,"median":-8.332111,"eighty":-7.228474,"marketCap":956353234},{"date":"2025-08-29","current":-8.648626,"twenty":-19.29215,"median":-8.429698,"eighty":-7.242061,"marketCap":903521996},{"date":"2025-09-05","current":-10.155428,"twenty":-19.267816,"median":-8.442215,"eighty":-7.274671,"marketCap":1060937523},{"date":"2025-09-12","current":-9.247219,"twenty":-19.117195,"median":-8.531282,"eighty":-7.282823,"marketCap":966056931},{"date":"2025-09-19","current":-8.911801,"twenty":-19.040911,"median":-8.561886,"eighty":-7.298422,"marketCap":931015804},{"date":"2025-09-26","current":-8.416414,"twenty":-18.814066,"median":-8.561394,"eighty":-7.303028,"marketCap":879262754},{"date":"2025-10-03","current":-9.592957,"twenty":-18.486847,"median":-8.591998,"eighty":-7.324944,"marketCap":1002176247},{"date":"2025-10-10","current":-10.212191,"twenty":-18.290115,"median":-8.630565,"eighty":-7.351996,"marketCap":1066867560},{"date":"2025-10-17","current":-11.4971,"twenty":-18.113457,"median":-8.648626,"eighty":-7.357523,"marketCap":1201102033},{"date":"2025-10-24","current":-10.903668,"twenty":-17.908694,"median":-8.694854,"eighty":-7.362988,"marketCap":1139106192},{"date":"2025-10-31","current":-13.298037,"twenty":-17.320504,"median":-8.903157,"eighty":-7.366819,"marketCap":1389245933},{"date":"2025-11-07","current":-10.460565,"twenty":-17.071577,"median":-8.919541,"eighty":-7.375835,"marketCap":1278553063},{"date":"2025-11-14","current":-10.319087,"twenty":-16.746366,"median":-8.953083,"eighty":-7.3842,"marketCap":1261260713},{"date":"2025-11-21","current":-11.035322,"twenty":-16.535581,"median":-9.042102,"eighty":-7.390371,"marketCap":1348803231},{"date":"2025-11-28","current":-12.644639,"twenty":-16.41714,"median":-9.068084,"eighty":-7.395598,"marketCap":1545503702},{"date":"2025-12-05","current":-12.264416,"twenty":-16.306728,"median":-9.154334,"eighty":-7.402392,"marketCap":1499030514},{"date":"2025-12-12","current":-12.145044,"twenty":-16.258549,"median":-9.253501,"eighty":-7.413262,"marketCap":1484440094},{"date":"2025-12-19","current":-13.201711,"twenty":-16.238474,"median":-9.412348,"eighty":-7.419454,"marketCap":1613592327},{"date":"2025-12-26","current":-13.38298,"twenty":-16.206354,"median":-9.577476,"eighty":-7.422171,"marketCap":1635748149},{"date":"2026-01-02","current":-12.003565,"twenty":-15.686418,"median":-9.608438,"eighty":-7.426849,"marketCap":1467147745},{"date":"2026-01-09","current":-12.175992,"twenty":-13.691713,"median":-9.623919,"eighty":-7.437719,"marketCap":1488222796},{"date":"2026-01-16","current":-13.661516,"twenty":-14.223893,"median":-9.706483,"eighty":-7.459459,"marketCap":1669792461},{"date":"2026-01-23","current":-14.055003,"twenty":-14.055003,"median":-9.763246,"eighty":-7.459459,"marketCap":1717886807},{"date":"2026-01-30","current":-13.679201,"twenty":-14.055003,"median":-9.837934,"eighty":-7.487886,"marketCap":1671954005},{"date":"2026-02-06","current":-11.495127,"twenty":-13.997527,"median":-9.967119,"eighty":-7.498759,"marketCap":1405003366},{"date":"2026-02-13","current":-5.659139,"twenty":-13.966579,"median":-10.045793,"eighty":-7.487886,"marketCap":691693964},{"date":"2026-02-20","current":-3.775707,"twenty":-13.794285,"median":-9.921951,"eighty":-7.430925,"marketCap":461489567},{"date":"2026-02-27","current":-3.49275,"twenty":-13.743121,"median":-9.768407,"eighty":-7.40375,"marketCap":426904868},{"date":"2026-03-06","current":-3.391062,"twenty":-13.712802,"median":-9.724309,"eighty":-7.375835,"marketCap":414475992},{"date":"2026-03-13","current":-4.171405,"twenty":-13.705728,"median":-9.63424,"eighty":-7.351996,"marketCap":509854106},{"date":"2026-03-20","current":-3.704968,"twenty":-13.684506,"median":-9.611018,"eighty":-7.282823,"marketCap":452843392},{"date":"2026-03-27","current":-3.71417,"twenty":-13.665053,"median":-9.577476,"eighty":-7.221038,"marketCap":532771662},{"date":"2026-04-02","current":-3.532065,"twenty":-13.632336,"median":-9.412348,"eighty":-7.146004,"marketCap":506650069},{"date":"2026-04-10","current":-3.953182,"twenty":-13.517385,"median":-9.253501,"eighty":-6.612231,"marketCap":567056254},{"date":"2026-04-17","current":-3.831779,"twenty":-13.45372,"median":-9.154334,"eighty":-6.50272,"marketCap":549641858},{"date":"2026-04-24","current":-3.642087,"twenty":-13.411276,"median":-9.068084,"eighty":-6.341219,"marketCap":522431865},{"date":"2026-05-01","current":-3.482746,"twenty":-13.38298,"median":-9.030487,"eighty":-6.247466,"marketCap":499575471},{"date":"2026-05-08","current":-3.408766,"twenty":-13.356783,"median":-8.950503,"eighty":-6.042298,"marketCap":488963574},{"date":"2026-05-15","current":-3.051413,"twenty":-13.336336,"median":-8.911801,"eighty":-5.873814,"marketCap":478351676},{"date":"2026-05-22","current":-2.936855,"twenty":-13.312561,"median":-8.871357,"eighty":-5.82388,"marketCap":460393081},{"date":"2026-05-29","current":-2.888254,"twenty":-13.287802,"median":-8.694854,"eighty":-5.684399,"marketCap":452774283},{"date":"2026-06-05","current":-2.579294,"twenty":-13.258302,"median":-8.648626,"eighty":-5.496812,"marketCap":404340495},{"date":"2026-06-12","current":-2.214791,"twenty":-13.222933,"median":-8.630565,"eighty":-5.216676,"marketCap":347199510},{"date":"2026-06-18","current":-2.134948,"twenty":-13.191984,"median":-8.604831,"eighty":-4.257618,"marketCap":334682913},{"date":"2026-06-26","current":-2.207848,"twenty":-13.129203,"median":-8.561886,"eighty":-4.092265,"marketCap":346111110},{"date":"2026-07-02","current":-2.527222,"twenty":-13.033705,"median":-8.501661,"eighty":-3.922831,"marketCap":396177498},{"date":"2026-07-10","current":-2.71121,"twenty":-12.989493,"median":-8.446844,"eighty":-3.831779,"marketCap":425020090},{"date":"2026-07-17","current":-2.509865,"twenty":-12.97623,"median":-8.429698,"eighty":-3.775707,"marketCap":393456498},{"date":"2026-07-24","current":-2.221734,"twenty":-12.962966,"median":-8.408673,"eighty":-3.733139,"marketCap":348287910},{"date":"2026-07-31","current":-2.280749,"twenty":-12.929663,"median":-8.332111,"eighty":-3.686663,"marketCap":357539308},{"date":"2026-08-07","current":-2.384893,"twenty":-12.91308,"median":-8.260764,"eighty":-3.654227,"marketCap":373865303},{"date":"2026-08-14","current":-2.418325,"twenty":-12.836708,"median":-8.229183,"eighty":-3.58648,"marketCap":378467893},{"date":"2026-08-21","current":-2.397327,"twenty":-12.813742,"median":-8.043715,"eighty":-3.543056,"marketCap":375181630},{"date":"2026-08-24","current":-2.439324,"twenty":-12.812645,"median":-8.026772,"eighty":-3.532065,"marketCap":381754155}],"updateTime":1787656621673},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"UPB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659173458","title":"LifeSci Capital Sticks to Its Buy Rating for Upstream Bio, Inc. (UPB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659173458","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659173458?lang=en_us&edition=fundamental","pubTime":"2026-08-15 22:35","pubTimestamp":1786804511,"startTime":"0","endTime":"0","summary":"In a report released today, Kate Dellorusso from LifeSci Capital maintained a Buy rating on Upstream Bio, Inc., with a price target of $19.00. Acco...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-buy-rating-for-upstream-bio-inc-upb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-buy-rating-for-upstream-bio-inc-upb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659393123","title":"Upstream Bio Price Target Raised to $9.00/Share from $8.00 by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2659393123","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659393123?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:24","pubTimestamp":1786724640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/UPB/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659498161","title":"J.P. Morgan Keeps Their Hold Rating on Upstream Bio, Inc. (UPB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659498161","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659498161?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:56","pubTimestamp":1786708598,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Tessa Romero maintained a Hold rating on Upstream Bio, Inc. today and set a price target of $9.00. According to TipRanks, Romer...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-keeps-their-hold-rating-on-upstream-bio-inc-upb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-keeps-their-hold-rating-on-upstream-bio-inc-upb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658265829","title":"Analysts Offer Insights on NA Companies: Upstream Bio, Inc. (UPB) and Circle Internet Group, Inc. Class A (CRCL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658265829","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658265829?lang=en_us&edition=fundamental","pubTime":"2026-08-12 13:30","pubTimestamp":1786512614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Upstream Bio, Inc. (UPB) and Circle Internet Group, Inc. Cla...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-upstream-bio-inc-upb-and-circle-internet-group-inc-class-a-crcl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-upstream-bio-inc-upb-and-circle-internet-group-inc-class-a-crcl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","LU1861559042.SGD","CRCD","IBLC","LU0106831901.USD","CRCL","LU1861217088.USD","BLCK","LU1668664300.SGD","CRCG","BKCH","BK4139","LU1791807156.HKD","UPB","CCUP","CRCA","CRCO","ICRC","LU1861220207.SGD","BK4023","LU2360107671.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658221910","title":"Matt Phipps Initiates Buy on Upstream Bio, Citing Favorable FDA Progress and Best-in-Class Potential for Verekitug","url":"https://stock-news.laohu8.com/highlight/detail?id=2658221910","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658221910?lang=en_us&edition=fundamental","pubTime":"2026-08-12 03:05","pubTimestamp":1786475121,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their bullish stance on UPB stock, giving a Buy rating today. Matt Phipps has given his Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/matt-phipps-initiates-buy-on-upstream-bio-citing-favorable-fda-progress-and-best-in-class-potential-for-verekitug-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/matt-phipps-initiates-buy-on-upstream-bio-citing-favorable-fda-progress-and-best-in-class-potential-for-verekitug-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4097","BK4588","BK4139","LU2065732104.USD","UPB","PRGS","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658091067","title":"Upstream Bio price target lowered to $25 from $43 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2658091067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658091067?lang=en_us&edition=fundamental","pubTime":"2026-08-12 02:55","pubTimestamp":1786474522,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on Upstream Bio (UPB) to $25 from $43 and keeps a Buy rating on the shares. Following the Q2 business update...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/upstream-bio-price-target-lowered-to-25-from-43-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/upstream-bio-price-target-lowered-to-25-from-43-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997865","title":"Upstream Bio Q2 EPS $(0.73) Beats $(0.76) Estimate, Sales $773.000K Beat $430.714K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997865","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997865?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:33","pubTimestamp":1786448027,"startTime":"0","endTime":"0","summary":"Upstream Bio (NASDAQ:UPB) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.76) by 3.95 percent. This is a 1.35 percent increase over losses of $(0.74) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61104108/upstream-bio-q2-eps-0-73-beats-0-76-estimate-sales-773-000k-beat-430-714k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992726","title":"Gain Therapeutics Q2 Net Loss Per Share Narrows as R&D Expenses Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992726","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992726?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:29","pubTimestamp":1786447746,"startTime":"0","endTime":"0","summary":"Gain Therapeutics Q2 net loss per share narrows as R&D expenses fallOverviewBiotechnology firm's Q2 net loss per share narrowed yr/yr to $0.11R&D expenses fell due to lower costs for lead compound and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480EJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GANX","BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992214","title":"Upstream Bio Posts Corporate Presentation Highlighting Verekitug Phase 3 Plans in Severe Asthma, CRSwNP","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992214","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992214?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:24","pubTimestamp":1786447458,"startTime":"0","endTime":"0","summary":"Upstream Bio posts corporate presentation highlighting verekitug Phase 3 plans in severe asthma, CRSwNPUpstream Bio outlined plans to meet FDA in mid-2026, with Phase 3 starts in severe asthma and CRS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL1Q1xvk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992965","title":"Upstream Bio Q2 Net Loss Narrows Slightly on Lower R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992965","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992965?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:14","pubTimestamp":1786446875,"startTime":"0","endTime":"0","summary":"Upstream Bio Q2 net loss narrows slightly on lower R&D costsOverviewUS biotech firm reported Q2 collaboration revenue declined yr/yrQ2 net loss narrowed slightly from same period last yrCompany comple","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","MGX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658994461","title":"Upstream Bio Inc Q2 Collaboration Revenue USD 773 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2658994461","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658994461?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:00","pubTimestamp":1786446001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nPLX20FP6J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657680830","title":"Press Release: Onity Group Announces Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657680830","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657680830?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:45","pubTimestamp":1786013100,"startTime":"0","endTime":"0","summary":"-- Adjusted pre-tax income* of $14 million, resulting in annualized adjusted. -- Net loss includes $9 million pre-tax cost related to reverse asset sale. and legacy subservicing transfer and $24 million pre-tax unfavorable. -- $283 million in total revenue, up 15% vs Q2 2025; $281 million in. -- $42 billion in total servicing additions, including quarterly record of. over $15 billion in Originations, up 64% vs Q2 2025; $341 billion in. ending servicing UPB, up 10% vs Q2 20252026 Outlook:-- Maintained adjusted ROE* guidance range at 10% - 15%, expected to be at. the lower end of the range, in light of persistent geopolitical. -- Reaffirming previous guidance on servicing UPB growth, MSR hedge. reverse assets; sold approximately 80% of reverse MSRs, based on fair","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDST","UMI","ENFR","ET","AMZA","BK4561","AMLP","BK4139","UPB","BK4229","BK4581","BK4590","EIPX","BK4585","ONIT","BK4588","USAI","EIPI","BK4144","TPZ","TNGY","EMLP","MLPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655649193","title":"Upstream Bio Inc Expected to Post a Loss of 76 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2655649193","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655649193?lang=en_us&edition=fundamental","pubTime":"2026-07-31 21:52","pubTimestamp":1785505927,"startTime":"0","endTime":"0","summary":"Upstream Bio Inc <UPB.OQ> expected to post a loss of76cents a share - Earnings PreviewUpstream Bio IncUPB.OQUPB.Ois expected to  show a fall in quarterly revenue when it reports  results on August 4 (","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL8N43X24F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655361378","title":"Arbor Realty Trust Reports Second Quarter 2026 Results and Declares Dividend of $0.17 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2655361378","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655361378?lang=en_us&edition=fundamental","pubTime":"2026-07-31 20:30","pubTimestamp":1785501000,"startTime":"0","endTime":"0","summary":"Company Highlights: GAAP net loss of $(37.3) million, or $(0.20) per diluted common shareDistributable earnings1 of $0.10 per diluted common share, or $0.15 excluding $9.6 million of net realized loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/31/3336797/0/en/Arbor-Realty-Trust-Reports-Second-Quarter-2026-Results-and-Declares-Dividend-of-0-17-per-Share.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DECU","GXDW","BK4110","UPB","ABR","VGFPF","FEBU","BK4139","JOYT","REET","PMDE","RGLO","HYIN","VOTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644897776","title":"Top Executive Makes Strategic Move With Upstream Bio Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2644897776","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644897776?lang=en_us&edition=fundamental","pubTime":"2026-06-18 10:10","pubTimestamp":1781748658,"startTime":"0","endTime":"0","summary":"New insider activity at Upstream Bio, Inc. ( ($UPB) ) has taken place on June 17, 2026. CEO Sutherland Everett Rand has recently sold 2,095 shares ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-strategic-move-with-upstream-bio-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-strategic-move-with-upstream-bio-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643324775","title":"Upstream Bio presents new responder analyses from VIBRANT trial of verekitug","url":"https://stock-news.laohu8.com/highlight/detail?id=2643324775","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643324775?lang=en_us&edition=fundamental","pubTime":"2026-06-15 04:55","pubTimestamp":1781470554,"startTime":"0","endTime":"0","summary":"Upstream Bio (UPB) presented new responder analyses from the Phase 2 VIBRANT trial of verekitug in participants with chronic rhinosinusitis with na...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/upstream-bio-presents-new-responder-analyses-from-vibrant-trial-of-verekitug-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/upstream-bio-presents-new-responder-analyses-from-vibrant-trial-of-verekitug-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643714241","title":"Upstream Bio says Phase 2 VIBRANT trial shows verekitug improves nasal polyp score in about 80% of CRSwNP patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2643714241","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643714241?lang=en_us&edition=fundamental","pubTime":"2026-06-14 22:00","pubTimestamp":1781445622,"startTime":"0","endTime":"0","summary":"Upstream Bio presented new post-hoc responder analyses from its Phase 2 VIBRANT trial of verekitug in chronic rhinosinusitis with nasal polyps at EAACI 2026.Quarterly dosing drove clinically meaningful symptom improvement for most treated participants, supporting a differentiated efficacy profile in severe, inadequately controlled disease.Management flagged plans to move into Phase 3 trials in CRSwNP, with a parallel Phase 3 program in severe asthma targeted for Q1 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260614:nNDL1DSxs7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU2095319765.USD","UPB","IE00BN0W2W23.USD","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4585","SG9999014021.USD","LU2210150020.SGD","SG9999014013.SGD","NDAQ","IE00BN0W2T93.GBP","BK4112","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643241272","title":"Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in Crswnp in Significant Majority of Participants Treated With Verekitug in the Phase 2 Vibrant Trial at Eaaci 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643241272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643241272?lang=en_us&edition=fundamental","pubTime":"2026-06-14 22:00","pubTimestamp":1781445600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260614:nTUA1QTH4F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642889254","title":"Upstream Bio Inc : JP Morgan Cuts to Neutral From Overweight; Cuts Target Price to $8 From $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2642889254","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642889254?lang=en_us&edition=fundamental","pubTime":"2026-06-12 12:55","pubTimestamp":1781240111,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42J0VK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642479907","title":"Upstream Bio Shareholders Elect Directors, Ratify 2026 Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2642479907","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642479907?lang=en_us&edition=fundamental","pubTime":"2026-06-11 05:04","pubTimestamp":1781125470,"startTime":"0","endTime":"0","summary":"An announcement from Upstream Bio, Inc. ( ($UPB) ) is now available. Upstream Bio, Inc. held its 2026 Annual Meeting of Stockholders on June 9, 202...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/upstream-bio-shareholders-elect-directors-ratify-2026-auditor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/upstream-bio-shareholders-elect-directors-ratify-2026-auditor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UPB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}]}}